Acute pancreatitis in HIV/AIDS patients:an issue of concern

作     者：Gordana Dragovic 

作者机构：Institute of PharmacologyClinical Pharmacology and ToxicologySchool of MedicineUniversity of Belgrade 

出 版 物：《Asian Pacific Journal of Tropical Biomedicine》 (亚太热带生物医学杂志（英文版）)

年 卷 期：2013年第3卷第6期

页      面：422-425页

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：part of the project of the FP 6 program(Grant No.:175024) supported by Ministry of Science and Technological Development of Serbia together with "European AIDS Treatment Network"(NEAT):LSHPCT-2006-037570 

主　　题：Acute pancreatitis Nucleoside reverse transcriptase inhibitors Protease inhibitors CD cells count Gender 

摘      要：Pancreatitis is a well-described complication of human immunodeficiency virus(HIV)itself and its comhinalion antiretroviral ***,this has been predominantly associated with the usage of nucleoside reverse transcriptase inhibitors such as didanosine and *** only rarely with the usage of protease inhibitors via the induction of *** rales in HIV/AIDS population may have been exceedingly high because of the comorbid conditions prevalent in HIV/AIDS patients(*** use and biliary disease),and the use of noncombinalion antiretroviral therapy medications such as pentamidine,corticosteroids,***,metronidazole,isoniazid and opportunistic infections(***,*** disease).In resource limited settings,where didanosine and stavudine are widely available in cheaper generic lived dose combinations it is likelv that their usage will remain in the first line HIV treatment in *** such settings management or estimation of a patient s risk of pancreatitis still remains an issue of concern.